Damien ROUX

Nationality French
Year of selection2010
InstitutionThe Brigham and Women's Hospital, Inc,
CountryUnited Kingdom
RiskLife risks

Type of support

Post-Doctoral Fellowship

Granted amount

90 000 €


1.5 years

Prevent pneumonia in hospitalized patients

Hospital-acquired infections are the fourth leading cause of patient death. Doctor Roux is tackling the most prevalent of these nosocomial infections – pneumonia – caused by the bacteria Pseudomonas aeruginosa. He began by successfully identifying the proteins responsible for the passage of bacteria from the environment into the guts of immunosuppressed mice. These are perfect targets for hospital-acquired infections, mimicking hospitalized patients weakened by anti-cancer or anti-burn treatments. Dr. Roux has also singled out the genetic mechanisms for the bacteria’s acquired resistance to antibiotics. He is now investigating Pseudomonas infection in the lungs. Indeed, in hospitals, these bacteria are most often found in ventilator-associated pneumonia. The in-depth and thorough understanding of Pseudomonas aeruginosa infection provided by Dr. Roux’s research could soon result in a vaccine against pneumonia and the other diseases caused by these bacteria.

To add or modify information on this page, please contact us at the following address: community.research@axa.com